Nature, Published online: 12 August 2026; doi:10.1038/s41586-026-10925-6 Potential predictive biomarkers of perioperative nivolumab therapy benefit in non-small cell lung cancer are identified from evaluable participants in the CheckMate…
View original source — Nature ↗

